Find a MS Trial
Preventing the risk of MS using vitamin D in patients with a first demyelinating event in Australia and New Zealand (PrevANZ)
August 29, 2013
Location: NSW, NZ, QLD, SA, TAS, VIC, WA
Type of study/intervention: Drug
Recruitment Status: Closed
Form of MS: Clinically isolated syndrome, Optic neuritis
